Join
Live feed
·
INSIDERFilingvia Quantisnow
Collegium Pharmaceutical Inc. logo

EVP and Chief Medical Officer Smith Thomas B sold $351,320 worth of shares (9,593 units at $36.62), decreasing direct ownership by 15% to 53,816 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
COLL· Collegium Pharmaceutical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COLL (Collegium Pharmaceutical Inc.) and more on Quantisnow.